Product information and disease descriptionProduct descriptionProduct information
Special populations
7 evidence topics · 7 sources
Age range of the pivotal cohort: females aged 6 to under 22 years
Children aged 5 to 8 years: REVEAL Pediatric trial
Children aged over 2 to under 4 years: ASPIRE trial
Extrapolation of efficacy to children aged 2 to under 6 years
Paediatric subsets and studies agreed in the European Union paediatric investigation plan
Sex: the trials enrolled females
Participants requiring invasive ventilatory support were excluded
Pregnancy, lactation, renal impairment, and hepatic impairment
No evidence found.